Luna-Nophal, A.; DÃaz-Castillo, F.; Izquierdo-Sánchez, V.; Velázquez-Fernández, J.B.; Orozco-Morales, M.; Lara-MejÃa, L.; Bernáldez-Sarabia, J.; Sánchez-Campos, N.; Arrieta, O.; DÃaz-Chávez, J.;
et al. Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma. Mar. Drugs 2025, 23, 32.
https://doi.org/10.3390/md23010032
AMA Style
Luna-Nophal A, DÃaz-Castillo F, Izquierdo-Sánchez V, Velázquez-Fernández JB, Orozco-Morales M, Lara-MejÃa L, Bernáldez-Sarabia J, Sánchez-Campos N, Arrieta O, DÃaz-Chávez J,
et al. Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma. Marine Drugs. 2025; 23(1):32.
https://doi.org/10.3390/md23010032
Chicago/Turabian Style
Luna-Nophal, Angélica, Fernando DÃaz-Castillo, Vanessa Izquierdo-Sánchez, Jesús B. Velázquez-Fernández, Mario Orozco-Morales, Luis Lara-MejÃa, Johana Bernáldez-Sarabia, Noemà Sánchez-Campos, Oscar Arrieta, José DÃaz-Chávez,
and et al. 2025. "Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma" Marine Drugs 23, no. 1: 32.
https://doi.org/10.3390/md23010032
APA Style
Luna-Nophal, A., DÃaz-Castillo, F., Izquierdo-Sánchez, V., Velázquez-Fernández, J. B., Orozco-Morales, M., Lara-MejÃa, L., Bernáldez-Sarabia, J., Sánchez-Campos, N., Arrieta, O., DÃaz-Chávez, J., Castañeda-Sánchez, J.-I., Licea-Navarro, A.-F., & Muñiz-Hernández, S.
(2025). Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma. Marine Drugs, 23(1), 32.
https://doi.org/10.3390/md23010032
